DPDP compliance for pharma companies is complex because a single organisation processes data of patients, trial participants, doctors, field staff and plant workers, often across borders. For Hyderabad’s pharma and life sciences cluster, the DPDP Act now adds Indian privacy obligations to existing GxP, GDPR and HIPAA programmes.
Hyderabad is India’s pharmaceutical and life sciences capital. Bulk drug manufacturers, formulation companies, CROs, CDMOs, biotech startups in Genome Valley and global pharma GCCs all process personal data. The DPDP Act, 2023 applies to each of these, and the sector’s data is both high-volume and high-sensitivity.
Personal data in a pharma value chain
- Clinical trial participants: identity, contact and health data collected through sites and CROs
- Patient support programmes: adherence, refill reminders, nurse calls and co-pay assistance
- Pharmacovigilance: adverse event reports containing patient and reporter details
- Healthcare professionals: doctor profiles, prescribing interactions, speaker programmes and payments
- Field force: medical representatives’ location, call logs and expense records
- Employees and contract workers at plants and R&D centres
- Consumer health: OTC brand campaigns, apps and helplines
Key DPDP questions for pharma
Who is the Data Fiduciary in a trial? Sponsors, CROs and sites each play roles. Contracts must allocate responsibilities clearly, and the trial informed consent process should be aligned with DPDP notice requirements, alongside the New Drugs and Clinical Trials Rules and ethics committee requirements.
Can pharmacovigilance data be processed without consent? Where processing is required to comply with a legal obligation, Section 7 legitimate uses may apply. Document the legal basis for each adverse event processing activity.
Patient support programmes These typically rely on consent. They must offer an easy withdrawal route that reaches every vendor in the programme: call centres, nursing agencies, logistics and digital platforms.
HCP data Doctor data used for engagement and marketing needs a lawful basis and a clear notice. Purchased HCP databases need provenance checks.
Field force tracking Location tracking of medical representatives may fall within employment purposes, but should be proportionate and transparent.
Cross-border data flows
Hyderabad pharma companies routinely send data to global safety databases, trial sponsors and parent companies. Section 16 of the DPDP Act permits transfers outside India except to countries the government restricts by notification, and sectoral laws with stricter requirements continue to apply. Maintain a transfer register and contractual safeguards.
Aligning with global programmes
Many Hyderabad life sciences companies already run GDPR and HIPAA programmes. Reuse these controls, but remember DPDP’s differences: no general legitimate interests basis, under-18 children’s rules, mandatory reporting of all breaches, and Board-specific notification content.
Priority actions
- Map data across clinical, safety, medical affairs, commercial, HR and manufacturing
- Align informed consent and patient programme notices with DPDP
- Review CRO, site, call centre and agency contracts
- Build a transfer register for global systems
- Integrate DPDP breach reporting with pharmacovigilance and IT incident processes
DPDP compliance for pharma companies across Hyderabad
Our DPDP consultants in Hyderabad work with formulation and API manufacturers, CROs, CDMOs, biotech firms in Genome Valley and pharma GCCs in HITEC City and the Financial District. We map clinical, safety, medical affairs, commercial, HR and manufacturing data, align consent and patient programme notices, review CRO and agency contracts, and build a cross-border transfer register for global systems, reusing your existing GDPR and HIPAA controls.
Frequently asked questions
Do Hyderabad CROs need their own DPDP compliance programme? Yes. CROs act as Fiduciaries for their own data and usually as Processors for sponsors, so they need both internal compliance and processor-grade controls.
Is health data treated as a special category under DPDP? DPDP does not create separate sensitive data categories, but the risk of harm and the security expectations are higher for health data.
Do we need consent for adverse event reporting? Regulatory reporting obligations may provide a lawful basis without consent. Document it.
Can we transfer trial data to a global sponsor? Yes, unless the destination is restricted by government notification, with appropriate contracts and safeguards.
Speak to our DPDP consultants in Hyderabad. Request a DPDP review tailored to pharma and life sciences